PATENT CLAIM ANALYSIS

Application Number: 15761403
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "04400R"]

Abstract:
The described invention provides a method for reducing progression of lung fibrosis after a lung injury comprising administering a therapeutic amount of a therapeutic agent, wherein the therapeutic amount is effective: (a) to modulate expression of a T-box transcription factor in a population of cells in lung; and (b) to reduce proliferation of the population of cells in lung expressing the T-box transcription factor. According to some embodiments the T-box transcription factor is Tbx4.

Claim (Index 6):
The method according to  claim 5 , wherein the population of cells in lung in which Tbx4 is expressed comprises one or more of a population of pericytes, a population of lipofibroblasts, a population of endothelial cells, or a population of myofibroblasts.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 90.0
- Lexical Diversity: 1.76596
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14718933', '14111338', '13445759', '14473339', '15855398']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7811991560629108
- 35 USC 102 Novelty (BERT): 0.523004336164598
- Combined Prediction Score: 0.7553796740730795
- Mean Citation Score: 315.22183800000005
- Max Citation Score: 325.937
- Similarity Product: 239.99170381098983

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test